Literature DB >> 1425051

Outcome of ileorectal anastomosis for Crohn's colitis.

W E Longo1, J R Oakley, I C Lavery, J M Church, V W Fazio.   

Abstract

One hundred thirty-one patients underwent ileorectal anastomosis (IRA) for Crohn's colitis. Preoperatively, 84 patients (63 percent) were found to have mild or moderate proctitis and 47 (37 percent) had rectal sparing. Sixty-eight (52 percent) had associated small bowel disease, and 20 (15 percent) had perianal disease. Sixty-five IRAs were performed at the time of subtotal colectomy, while 56 were done after previous surgery. Anastomotic leaks occurred in four patients. There were no operative deaths. Thirteen patients (10 percent) with protecting stomas never underwent closure. Among the remaining 118 patients with functioning IRAs, 30 (23 percent) required later proctectomy and 16 (13 percent) required proximal diversion, with the mean period with a functioning IRA in these 46 patients being 4.1 years (range, 6.2 months-12.7 years). An additional 13 patients required preanastomotic resection and neo-IRA, and 11 required proximal small bowel resection. The mean duration of function of all 118 IRAs was 9.2 years. At the time of review, after a mean follow-up of 9.5 years, 72 patients (61 percent) retained a functioning IRA, with 44 being free of disease, while 28 were being treated with steroids or antidiarrheal medication. The mean stool frequency was 4.7 per day. In patients with Crohn's colitis, IRA should be considered as an alternative to proctocolectomy if the rectum is not severely diseased and sphincter function is not compromised.

Entities:  

Mesh:

Year:  1992        PMID: 1425051     DOI: 10.1007/bf02252997

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  11 in total

Review 1.  Surgery for luminal Crohn's disease.

Authors:  Takayuki Yamamoto; Toshiaki Watanabe
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

2.  New perspectives on the long-term outcome of segmental colectomy for Crohn's colitis: an observational study on 200 patients.

Authors:  Stefano Scaringi; Annamaria Di Bella; Luca Boni; Francesco Giudici; Carmela Di Martino; Daniela Zambonin; Ferdinando Ficari
Journal:  Int J Colorectal Dis       Date:  2018-03-06       Impact factor: 2.571

Review 3.  Is There a Role for Ileal Pouch Anal Anastomosis in Crohn's Disease?

Authors:  Nicole E Lopez; Karen Zaghyian; Phillip Fleshner
Journal:  Clin Colon Rectal Surg       Date:  2019-06-17

Review 4.  Reoperative Surgery in Complex Crohn's Disease.

Authors:  Jennifer A Leinicke; David W Dietz
Journal:  Clin Colon Rectal Surg       Date:  2019-07-02

5.  Risk factors for proctectomy in consecutive Crohn's colitis surgical patients in a reference colorectal centre.

Authors:  Gisele Aaltonen; Monika Carpelan-Holmström; Ilona Keränen; Anna Lepistö
Journal:  Int J Colorectal Dis       Date:  2019-06-28       Impact factor: 2.571

Review 6.  Colonic crohn disease.

Authors:  Traci L Hedrick; Charles M Friel
Journal:  Clin Colon Rectal Surg       Date:  2013-06

7.  Postoperative outcome of Crohn's disease in 30 children.

Authors:  M Besnard; O Jaby; J F Mougenot; L Ferkdadji; A Debrun; C Faure; P Delagausie; M Peuchmaur; Y Aigrain; J Navarro; J P Cézard
Journal:  Gut       Date:  1998-11       Impact factor: 23.059

8.  Repeat ileal pouch-anal anastomosis to salvage septic complications of pelvic pouches: clinical outcome and quality of life assessment.

Authors:  V W Fazio; J S Wu; I C Lavery
Journal:  Ann Surg       Date:  1998-10       Impact factor: 12.969

Review 9.  Indications and Specific Surgical Techniques in Crohn's Disease.

Authors:  Claudia Seifarth; Martin E Kreis; Jörn Gröne
Journal:  Viszeralmedizin       Date:  2015-08-14

10.  Surgical Treatment of Crohn Colitis Involving More Than 2 Colonic Segments: Long-Term Outcomes From a Single Institution.

Authors:  Jong Lyul Lee; Chang Sik Yu; Seok-Byung Lim; In Ja Park; Yong Sik Yoon; Chan Wook Kim; Suk-Kyun Yang; Jin Cheon Kim
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.